1844: Intellectual movements. Bibliography (p. 213-240) PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download 1844: Intellectual movements. Bibliography (p. 213-240) PDF full book. Access full book title 1844: Intellectual movements. Bibliography (p. 213-240) by Jerome Leslie Clark. Download full books in PDF and EPUB format.
Author: Jerome Leslie Clark
Publisher:
ISBN:
Category : Eighteen forty-four, A.D.
Languages : en
Pages : 248
Get Book Here
Book Description
Author: Jerome Leslie Clark
Publisher:
ISBN:
Category : Eighteen forty-four, A.D.
Languages : en
Pages : 248
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Union catalogs
Languages : en
Pages : 680
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : American literature
Languages : en
Pages : 664
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Union catalogs
Languages : en
Pages : 666
Get Book Here
Book Description
Author: New York Public Library. Research Libraries
Publisher:
ISBN:
Category : Library catalogs
Languages : en
Pages : 562
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Books
Languages : en
Pages : 310
Get Book Here
Book Description
Author: R.R. Bowker Company. Department of Bibliography
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 2352
Get Book Here
Book Description
Author: American Psychiatric Association
Publisher: American Psychiatric Publishing
ISBN: 9780890425664
Category : Mental illness
Languages : en
Pages : 0
Get Book Here
Book Description
This handy DSM-5(R) Classification provides a ready reference to the DSM-5 classification of disorders, as well as the DSM-5 listings of ICD-9-CM and ICD-10-CM codes for all DSM-5 diagnoses. To be used in tandem with DSM-5(R) or the Desk Reference to the Diagnostic Criteria From DSM-5(R), the DSM-5(R) Classification makes accessing the proper diagnostic codes quick and convenient. With the advent of ICD-10-CM implementation in the United States on October 1, 2015, this resource provides quick access to the following: - The DSM-5(R) classification of disorders, presented in the same sequence as in DSM-5(R), with both ICD-9-CM and ICD-10-CM codes. All subtypes and specifiers for each DSM-5(R) disorder are included.- An alphabetical listing of all DSM-5 diagnoses with their associated ICD-9-CM and ICD-10-CM codes.- Separate numerical listings according to the ICD-9-CM codes and the ICD-10-CM codes for each DSM-5(R) diagnosis.- For all listings, any codable subtypes and specifiers are included with their corresponding ICD-9-CM or ICD-10-CM codes, if applicable. The easy-to-use format will prove indispensable to a diverse audience--for example, clinicians in a variety of fields, including psychiatry, primary care medicine, and psychology; coders working in medical centers and clinics; insurance companies processing benefit claims; individuals conducting utilization or quality assurance reviews of specific cases; and community mental health organizations at the state or county level.
Author: Friedrich List
Publisher:
ISBN:
Category : Economics
Languages : en
Pages : 422
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
